Introducing the advanced Navvus II Rapid Exchange FFR MicroCatheter.
This catheter delivers more flexibility than before and has a streamlined crossing profile to access complex lesions.
Navvus II and its predecessor, Navvus, are the only coronary physiology products that allow the use of your choice of 0.014” guidewires. This market distinction may enable faster, more efficient diagnostic and post-PCI physiological assessments because the wire position is maintained throughout the procedure.
Featuring improved flexibility1, reduced lesion entry profile2 and streamlined contouring to allow navigation of complex diseases.
Enables the physician to use 0.014” guidewire of choice and maintain wire position throughout the procedure including pullback and post-PCI assessments.
Fiber-optic sensor technology may be less susceptible to drift when compared to traditional pressure wires.3
Reduced Lesion Entry Profile
Improved Flexibility
1. TR-07888: Compared with Navvus® FFR MicroCatheter in benchtop testing. Data on file at ACIST. May not be indicative of clinical performance.
2. TR-08707: Compared with Navvus® FFR MicroCatheter in benchtop testing. Data on file at ACIST. May not be indicative of clinical performance.
3. William F. Fearon , Jeffrey W. Chambers, Arnold H. Seto, Ian J. Sarembock, Ganesh Raveendran, Charlotte Sakarovitch, Lingyao Yang, Manisha
Desai, Allen Jeremias, and Matthew J. Price and for the ACIST-FFR Study Investigators. Originally published15 Dec 2017https://doi.org/10.1161/
CIRCINTERVENTIONS.117.005905Circulation: Cardiovascular Interventions. 2017;10:e005905
